Joseph Wagner
Nessuna posizione attualmente
Patrimonio netto: - $ in data 30/04/2024
Profilo
Dr. Joseph P.
Wagner is a Chief Scientific Officer at Notable Labs Ltd.
Dr. Wagner was previously employed as a President, Chief Executive Officer & Director by BriaCell Therapeutics Corp., a President by Cell Targeting, Inc., a Vice President-Cellular Therapy by Neuronyx, Inc., and a Chief Executive Officer by OncoCyte Corp.
He received his undergraduate degree from Rochester Christian University and a doctorate degree from Duke University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 08/05/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Joseph Wagner
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Joseph Wagner
| Società | Posizione | Fine |
|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Amministratore Delegato | 24/03/2016 |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Corporate Officer/Principal | 13/10/2009 |
Cell Targeting, Inc.
 Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Presidente | - |
| ONCOCYTE CORPORATION | Amministratore Delegato | - |
Formazione di Joseph Wagner
| Rochester Christian University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Health Technology |
- Borsa valori
- Insiders
- Joseph Wagner
